Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
This startup leader is revealing entrepreneur answers (and they’re listed in the table of contents)
Aligning the stars as a forward-looking founder and business owner isn’t easy, Maria Flynn noted, so she wrote her own guidebook. “Entrepreneurs are my tribe of people,” said Flynn, a serial founder and regional digital health leader. “And I was telling the same stories over and over again, so I started to write them down.…
He earned industry cred alongside Ariana Grande; now Jo Blaq wants to share the music with emerging KC artists
Joseph Macklin forged a successful music career through trial and error, he said, but that doesn’t mean the next generation should be forced to endure those same challenges just to feel like they earned credibility. The multi-platinum, Grammy award-nominated music producer, songwriter, engineer, and vocal arranger — known as Jo Blaq — is on a…
Nation’s best dog bar planning new tricks in KC after fetching top award, summer funding round
The dog days of summer are bringing momentum to Bar K, said David Hensley. The Kansas City-based escape space for pets and their owners was recently named top dog in the country by USA Today, just closed a funding round, and added several key team members — including Tim Schoenfelder as CEO — the co-founder…
Let’s eat out: KCMO wants more outdoor dining; new grants program pays for restaurant upgrades
Outdoor dining’s economic impact outlasted the pandemic, said Mayor Quinton Lucas. A new push to boost KCMO businesses — with the backing of city tourism dollars — is expected to help local restaurants, coffee shops, and bars embrace the opportunity, he said. His goal: Make outdoor dining spaces even more attractive to visitors and hometown…